Sarcopenia and diabetes in elderly adults with type 2 diabetes
| ISRCTN | ISRCTN85256968 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN85256968 |
| Sponsor | Ambrosiana Nursing Home in Cesano Boscone, Piazza Monsignor Moneta |
| Funder | Ambrosiana Nursing |
- Submission date
- 01/10/2026
- Registration date
- 02/10/2026
- Last edited
- 06/10/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Maria Elena Malighetti
Principal investigator, Scientific, Public
Principal investigator, Scientific, Public
Piazza Monsignor Moneta, 1 - 20090 Cesano Boscone (MI)
Milano
20122
Italy
| Phone | +39 (0)3474243484 |
|---|---|
| mariaelena.malighetti@gmail.com |
Study information
| Primary study design | Observational |
|---|---|
| Observational study design | Cross sectional study |
| Scientific title | Prevalence and predictors of sarcopenia in elderly adults with type 2 diabetes: an Italian cross-sectional study |
| Study acronym | SARCODIAB |
| Study objectives | The study conducted at the community diabetes clinic in Cesano Boscone (Milan) aimed to assess the prevalence of sarcopenia in patients with type 2 diabetes mellitus (T2DM) followed at the clinic. |
| Ethics approval(s) |
Approved 23/06/2026, Territorial Ethics Committee Lombardy 3 (via Francesco Sforza 28, Milano, 20122, Italy; +39 (0)255032982; cetlombardia3@policlinico.mi.it), ref: ID 7296 – parere numero 7296_10.06.2026_P_bis |
| Health condition(s) or problem(s) studied | Sarcopenia in diabetic patients |
| Methodology | An observational, cross-sectional, retrospective study. Patient data will be extracted from the diabetes medical records held at the center: Initial functional assessment through two fundamental tests: 1. Handgrip test (manual grip strength): pathological if <32 kg in men and <19 kg in women 2. Chair Stand Test (CST): considered positive if the time required for five lifts from the chair - without aid - exceeds 12 seconds Instrumental examination: Only if both tests are positive, a muscle ultrasound of the quadriceps femoris is carried out to objectify the thickness of the muscle itself BMI indexing: 1. The value of muscle thickness (in cm) is divided by the patient's BMI to obtain the muscle/BMI index 2. Diagnostic cut-offs: 2.1. <1.4 in men 2.2. <1.0 in women Parameters and tests used: For patients included in the study, the following parameters were analyzed: 1. T0 blood tests: HbA1c, creatinine 2. Anthropometric evaluations: weight, height, BMI, waist circumference 3. Hypoglycemic therapy in progress Muscle functional tests: 1. Handgrip Test: evaluation of grip strength (kg) 2. Chair Standing Test (CST): measure of the time needed to perform five lifts from the chair with arms crossed 3. Muscle ultrasound of the quadriceps femoris (carried out if both of the above tests were positive) |
| Intervention type | Other |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) | |
| Completion date | 22/10/2025 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 60 Years |
| Upper age limit | 90 Years |
| Sex | All |
| Target sample size at registration | 1000 |
| Total final enrolment | 1000 |
| Key inclusion criteria | Documented diagnosis of type 2 diabetes in patients aged ≥65 years, or aged <65 years with at least one comorbidity associated with an increased risk of sarcopenia, including: CKD, RD, PAD, CVD, PN, obesity, chronic physical inactivity, metabolic liver disease, heart failure, depression, transplantation, steroid therapy, significant weight loss, osteoarthritis, cognitive decline, neurological diseases, history of cerebrovascular events, recent hospitalization, recurrent falls, chronic tiredness, fatigue, and progressive movement limitations. |
| Key exclusion criteria | 1. Unstable clinical status (acute infections, acute heart or renal failure) or neoplasms 2. Objective inability to perform the required functional tests |
| Date of first enrolment | 01/01/2025 |
| Date of final enrolment | 30/06/2025 |
Locations
Countries of recruitment
- Italy
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol file | 02/10/2026 | No | No |
Additional files
- 50383_Protocol.pdf
- Protocol file
Editorial Notes
06/10/2026: The contact and funder details were corrected.
05/10/2026: Internal review.
02/10/2026: Study's existence confirmed by the Territorial Ethics Committee Lombardy 3.